MDCXW (STOCKS)

    Medicus Pharma Ltd. Warrant

    Change: —
    Prev close: —
    Company Information
    Exchange
    XNAS
    Sector
    Industry
    CEO
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    Employees
    12
    P/E (TTM)
    P/B (TTM)
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Sep 2025)
    Revenues $75.09K
    Operating Expenses $14.73M
    Research and Development $6.50M
    Other Operating Expenses $23.66M
    Operating Income/Loss -$14.73M
    Income/Loss From Continuing Operations After Tax -$30.80M
    Income/Loss From Continuing Operations Before Tax -$30.80M
    Net Income/Loss -$30.80M
    Net Income/Loss Attributable To Noncontrolling Interest -$77.00
    Net Income/Loss Attributable To Parent -$35.75M
    Net Income/Loss Available To Common Stockholders, Basic -$35.75M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $77.00
    Preferred Stock Dividends And Other Adjustments $77.00
    Basic Earnings Per Share -$2.29
    Diluted Earnings Per Share -$2.29
    Basic Average Shares 45,738,397
    Diluted Average Shares 45,738,397
    Assets $9.98M
    Current Assets $9.78M
    Prepaid Expenses $1.12M
    Other Current Assets $8.66M
    Noncurrent Assets $196.25K
    Liabilities $10.78M
    Current Liabilities $10.66M
    Accounts Payable $2.03M
    Wages $297.30K
    Other Current Liabilities $8.33M
    Noncurrent Liabilities $124.65K
    Equity -$804.89K
    Equity Attributable To Noncontrolling Interest $105.24K
    Equity Attributable To Parent -$910.13K
    Liabilities And Equity $9.98M
    Net Cash Flow From Operating Activities -$19.36M
    Net Cash Flow From Operating Activities, Continuing -$19.36M
    Net Cash Flow From Investing Activities -$3.48M
    Net Cash Flow From Investing Activities, Continuing -$3.48M
    Net Cash Flow From Financing Activities $27.34M
    Net Cash Flow From Financing Activities, Continuing $27.34M
    Net Cash Flow $4.50M
    Net Cash Flow, Continuing $4.50M
    Comprehensive Income/Loss -$35.74M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $75.00
    Comprehensive Income/Loss Attributable To Parent -$35.74M
    Other Comprehensive Income/Loss -$4.94M